Abstract:The classsical way and understanding for bone resoprtion and loss is mediated by the monocytes/macrophage‐derived osteoclasts. The present study reveals a different alternative pathway for bone resorption and loss, which is done via the immature dendritic cell‐derived osteoclasts with different phenotypic and factional activities: for example, through the step‐wise cytokine cross talks, in an animal model of arthritic bone loss, in vivo Background Dendritic cells (DCs), though borne heterogeneous, are the most potent antigen‐presenting cells, whose critical functions include triggering antigen‐specific naïve T‐cell responses and fine‐tuning the innate versus adaptive immunity at the osteo‐immune and/or mucosal mesenchyme interface. We previously reported that immature myeloid‐CD11c+DCs/mDCs may act like osteoclast (OC) precursors (OCp/mDDOCp) capable of developing into functional OCs via an alternative pathway of inflammation‐induced osteoclastogenesis; however, what are their contribution and signaling interactions with key osteotropic cytokines (i.e., interleukin‐17 [IL‐17] and transforming growth factor‐β [TGF‐β]) to bearing such inflammatory bone loss in vivo remain unclear to date. Methods Herein, we employed mature adult bone marrow‐reconstituted C57BL/6 TRAF6(−/−)‐null chimeras without the classical monocyte/macrophage (Mo/Mφ)‐derived OCs to address their potential contribution to OCp/mDDOCp‐mediated osteoclastogenesis in the chicken type‐II‐collagen (CC‐II)‐induced joint inflammation versus arthritic bone loss and parallel associations with the double‐positive CD11c+TRAP+TRAF6‐null(−/−) DC‐like OCs detected in vivo via the quantitative dual‐immunohistochemistry and digital histomorphometry for analyses. Results The resulting findings revealed the unrecognized novel insight that (i) immature myeloid‐CD11c+TRAF6(−/−) TRAP+DC‐like OCs were involved, co‐localized, and strongly associated with joint inflammation and bone loss, independent of the Mo/Mφ‐derived classical OCs, in CC‐II‐immunized TRAF6(−/−)‐null chimeras, and (ii) the osteotropic IL‐17 may engage distinct crosstalk with CD11c+mDCs/mDDOCp before developing the CD11c+TRAP+TRAF6(−/−)OCs via a TGF‐β‐dependent interaction toward inflammation‐induced arthritic bone loss in vivo. Conclusion These results confirm and substantiate the validity of TRAF6(−/−)‐null chimeras to address the significance of immature mCD11c+TRAP+DC‐like OCs/mDDOCp subset for an alternative pathway of arthritic bone loss in vivo. Such CD11c+mDCs/mDDOCp‐associated osteoclastogenesis through the step‐wise twist‐in‐turns osteo‐immune cross talks are thereby theme highlighted to depict a summative re‐visitation proposed.

Crosstalk among IL-23 and DNAX Activating Protein of 12 Kda–dependent Pathways Promotes Osteoclastogenesis

Crosstalk among interleukin 23 and DNAX activating protein 12-dependent pathways promotes osteoclastogenesis

C/Ebp Alpha Regulates Osteoclast Lineage Commitment

TRAF6/ERK/p38 Pathway is Involved in Interleukin-17-mediated Autophagy to Promote Osteoclast Precursor Cell Differentiation.

Interleukin‑17A facilitates osteoclast differentiation and bone resorption via activation of autophagy in mouse bone marrow macrophages.

Molecular Basis of Requirement of Receptor Activator of Nuclear Factor Κb Signaling for Interleukin 1-Mediated Osteoclastogenesis.

Signaling crosstalk between RANKL and interferons in osteoclast differentiation

IL-1R/TLR2 Through MyD88 Divergently Modulates Osteoclastogenesis Through Regulation of Nuclear Factor of Activated T Cells C1 (nfatc1) and B Lymphocyte-induced Maturation Protein-1 (Blimp1)

Distinct cross talk of IL‐17 & TGF‐β with the immature CD11c+TRAF6(−/−)‐null myeloid dendritic cell‐derived osteoclast precursor (mDDOCp) may engage signaling toward an alternative pathway of osteoclastogenesis for arthritic bone loss in vivo

Interleukin-23 Mediates Osteoclastogenesis in Collagen-Induced Arthritis by Modulating MicroRNA-223

Interleukin-21 Promotes Osteoclastogenesis in RAW264.7 Cells Through the PI3K/AKT Signaling Pathway Independently of RANKL.

NF-κB promotes osteoclast differentiation by overexpressing MITF via down regulating microRNA-1276 expression

Non-Canonical (RANKL-Independent) Pathways of Osteoclast Differentiation and Their Role in Musculoskeletal Diseases

The molecular understanding of osteoclast differentiation

RBP-J–Regulated Mir-182 Promotes TNF-α–Induced Osteoclastogenesis

Interleukin-3 Plays Dual Roles in Osteoclastogenesis by Promoting the Development of Osteoclast Progenitors but Inhibiting the Osteoclastogenic Process

Decidual Γδt Cells Educated by CXCL16 Promotes Growth of JEG-3 Cells

Dysregulated myeloid differentiation in colitis is induced by inflammatory osteoclasts in a TNFα-dependent manner

Identification of a novel arthritis-associated osteoclast precursor macrophage regulated by FoxM1

IgG Immunocomplexes Drive the Differentiation of a Novel Subset of Osteoclasts Independent of RANKL and Inflammatory Cytokines

NADPH oxidase-derived reactive oxygen species are essential for differentiation of a mouse macrophage cell line (RAW264.7) into osteoclasts.